HCPCS code lookup

HCPCS Level II

S2107

Adoptive immunotherapy i.e. development of specific anti-tumor reactivity (e.g., tumor-infiltrating lymphocyte therapy) per course of treatment

Ask Rivvi

Code
S2107
Description
Adoptive immunotherapy i.e. development of specific anti-tumor reactivity (e.g., tumor-infiltrating lymphocyte therapy) per course of treatment

CMS HCPCS quarterly update

Try it on your own data today.

Free to start. Most teams are using it the same day.